This grant is for health departments in states and large cities, supporting integrated viral hepatitis surveillance and prevention programs. It focuses on viral hepatitis outbreak planning and response, alongside surveillance for acute hepatitis A, B, C, and chronic hepatitis C. Recipients are required to develop a jurisdictional viral hepatitis elimination plan, enhance comprehensive reporting, improve testing, and increase healthcare providers trained in treating hepatitis B and C. Contingent activities may include chronic hepatitis B and perinatal hepatitis C surveillance, expanded testing and referrals in high-impact settings like syringe service programs and substance use disorder treatment centers, and improved access to prevention services for people who inject drugs. The initiative aims to improve surveillance, foster stakeholder engagement, and enhance prevention, diagnosis, and treatment for at-risk populations.
Opportunity ID: 326479
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS21-2103 |
| Funding Opportunity Title: | Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 58 |
| Assistance Listings: | 93.270 — Viral Hepatitis Prevention and Control |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Aug 25, 2020 |
| Last Updated Date: | Oct 22, 2020 |
| Original Closing Date for Applications: | Dec 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Dec 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Dec 31, 2020 |
| Estimated Total Program Funding: | $341,020,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | County governments Special district governments City or township governments State governments |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control – NCHHSTP |
| Description: | This NOFO supports integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C. Recipients should develop a jurisdictional viral hepatitis elimination plan, increase comprehensive hepatitis B and C reporting, improve HBV and HCV testing and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder (SUD) treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics; and increased access to services preventing viral hepatitis and other infections among people who inject drugs (PWID). Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Gilberto Ramirez
GHR0@cdc.gov Email:GHR0@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modifications made by Program Officials | Oct 22, 2020 | |
| Modified by Drafter | Aug 25, 2020 | |
| Aug 25, 2020 | ||
| Apr 21, 2020 |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS21-2103 |
| Funding Opportunity Title: | Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 58 |
| Assistance Listings: | 93.270 — Viral Hepatitis Prevention and Control |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Aug 25, 2020 |
| Last Updated Date: | Oct 22, 2020 |
| Original Closing Date for Applications: | Dec 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Dec 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Dec 31, 2020 |
| Estimated Total Program Funding: | $341,020,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | County governments Special district governments City or township governments State governments |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control – NCHHSTP |
| Description: | This NOFO supports integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C. Recipients should develop a jurisdictional viral hepatitis elimination plan, increase comprehensive hepatitis B and C reporting, improve HBV and HCV testing and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder (SUD) treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics; and increased access to services preventing viral hepatitis and other infections among people who inject drugs (PWID). Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Gilberto Ramirez
GHR0@cdc.gov Email:GHR0@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS21-2103 |
| Funding Opportunity Title: | Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 58 |
| Assistance Listings: | 93.270 — Viral Hepatitis Prevention and Control |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Aug 25, 2020 |
| Last Updated Date: | Aug 27, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Dec 31, 2020 |
| Estimated Total Program Funding: | $341,020,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | State governments Special district governments City or township governments County governments |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control – NCHHSTP |
| Description: | This NOFO supports integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C. Recipients should develop a jurisdictional viral hepatitis elimination plan, increase comprehensive hepatitis B and C reporting, improve HBV and HCV testing and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder (SUD) treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics; and increased access to services preventing viral hepatitis and other infections among people who inject drugs (PWID). Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Gilberto Ramirez
GHR0@cdc.gov Email:GHR0@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS21-2103 |
| Funding Opportunity Title: | Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 58 |
| Assistance Listings: | 93.270 — Viral Hepatitis Prevention and Control |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 25, 2020 |
| Last Updated Date: | Aug 25, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Dec 31, 2020 |
| Estimated Total Program Funding: | $341,020,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | State governments Special district governments City or township governments County governments |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control – NCHHSTP |
| Description: | This NOFO supports integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C. Recipients should develop a jurisdictional viral hepatitis elimination plan, increase comprehensive hepatitis B and C reporting, improve HBV and HCV testing and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder (SUD) treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics; and increased access to services preventing viral hepatitis and other infections among people who inject drugs (PWID). Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Gilberto Ramirez
GHR0@cdc.gov Email:GHR0@cdc.gov |
DISPLAYING: Forecast 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS21-2103 |
| Funding Opportunity Title: | Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 58 |
| Assistance Listings: | 93.270 — Viral Hepatitis Prevention and Control |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 1 |
| Posted Date: | Apr 21, 2020 |
| Last Updated Date: | Apr 21, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | Dec 10, 2020 |
| Estimated Total Program Funding: | $341,020,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | State governments Special district governments City or township governments County governments |
| Additional Information on Eligibility: | This funding opportunity limits competition to state, county and city or township governments and their bona fide agents. These entities have the statutory authority to conduct viral hepatitis surveillance activities and to design, implement, and evaluate prevention programs and policies that impact communities. Also, the state health departments are the only entities required to receive reports of acute hepatitis B, acute hepatitis C, chronic hepatitis B, and perinatal and chronic hepatitis C from local health departments/jurisdictions and to notify (submit reported cases) CDC of reported cases. Eligible applicants are those who have the responsibility, authority, and ability to enforce laws, rules, or regulations pertaining to collecting and reporting of viral hepatitis surveillance data and those that have coordinated jurisdictional wide authority for viral hepatitis strategic planning for prevention and control activities at the state and local levels. The statutory language under Section 318 of the PHS Act (42 U.S.C. Sections 247c) provides CDC with the opportunity to provide project grants to the States and, in consultation with the State Health Authority, political subdivisions for, Sexually transmitted diseases surveillance activities, including the reporting, screening, and follow-up of diagnostic tests for, and diagnosed cases of, sexually transmitted diseases; As such this statutory language applies to viral hepatitis given the hepatitis B virus is transmitted when blood, semen, or another body fluid from a person infected with the virus enters the body of someone who is not infected. Although infrequent, hepatitis C can also be spread through sex with an HCV infected person. |
Additional Information
| Agency Name: | Centers for Disease Control – NCHHSTP |
| Description: | This NOFO supports integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C. Recipients should develop a jurisdictional viral hepatitis elimination plan, increase comprehensive hepatitis B and C reporting, improve HBV and HCV testing and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder (SUD) treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics; and increased access to services preventing viral hepatitis and other infections among people who inject drugs (PWID). Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:GHR0@cdc.gov |
Related Documents
Folder 326479 Revised Full Announcement-REVISED_FULL_ANNOUNCEMENT -> CDC-RFA-PS21-2103.pdf
Packages
| Agency Contact Information: | Gilberto Ramirez GHR0@cdc.gov Email: GHR0@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.270 | CDC-RFA-PS21-2103 | Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments | PKG00263151 | Aug 25, 2020 | Dec 01, 2020 | View |
Package 1
Mandatory forms
326479 SF424_2_1-2.1.pdf
326479 Project_AbstractSummary_2_0-2.0.pdf
326479 SFLLL_1_2-1.2.pdf
326479 SF424A-1.0.pdf
326479 BudgetNarrativeAttachments_1_2-1.2.pdf
326479 ProjectNarrativeAttachments_1_2-1.2.pdf
Optional forms
326479 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
